{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:33:01Z","timestamp":1793647981171,"version":"4.5.1"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P35628"],"award-info":[{"award-number":["P35628"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P35298"],"award-info":[{"award-number":["P35298"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["TAI490"],"award-info":[{"award-number":["TAI490"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nucleoporin 98 (NUP98) fusion oncoproteins are strong drivers of pediatric acute myeloid leukemia (AML) with poor prognosis. Here we show that\n                    <jats:italic>NUP98<\/jats:italic>\n                    fusion-expressing AML harbors an epigenetic signature that is characterized by increased accessibility of hematopoietic stem cell genes and enrichment of activating histone marks. We employ an AML model for ligand-induced degradation of the NUP98::KDM5A fusion oncoprotein to identify epigenetic programs and transcriptional targets that are directly regulated by NUP98::KDM5A through CUT&amp;Tag and nascent RNA-seq. Orthogonal genome-wide CRISPR\/Cas9 screening identifies 12 direct NUP98::KDM5A target genes, which are essential for AML cell growth. Among these, we validate cyclin-dependent kinase 12 (CDK12) as a druggable vulnerability in NUP98::KDM5A-expressing AML. In line with its role in the transcription of DNA damage repair genes, small-molecule-mediated CDK12 inactivation causes increased DNA damage, leading to AML cell death. Altogether, we show that NUP98::KDM5A directly regulates a core set of essential target genes and reveal CDK12 as an actionable vulnerability in AML with oncogenic\n                    <jats:italic>NUP98<\/jats:italic>\n                    fusions.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-59930-9","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T13:22:24Z","timestamp":1747660944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-4442","authenticated-orcid":false,"given":"Selina","family":"Troester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-2052","authenticated-orcid":false,"given":"Thomas","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Wukowits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Piontek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Fern\u00e1ndez-Pernas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8461-8881","authenticated-orcid":false,"given":"Johannes","family":"Schmoellerl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6903-7379","authenticated-orcid":false,"given":"Ben","family":"Haladik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Manhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Allram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3519-9972","authenticated-orcid":false,"given":"Margarita","family":"Maurer-Granofszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3091-2970","authenticated-orcid":false,"given":"Nastassja","family":"Scheidegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-541X","authenticated-orcid":false,"given":"Karin","family":"Nebral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0570-1768","authenticated-orcid":false,"given":"Giulio","family":"Superti-Furga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-3191","authenticated-orcid":false,"given":"Beat","family":"Bornhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-5095","authenticated-orcid":false,"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Dworzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8810-6835","authenticated-orcid":false,"given":"Johannes","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaan","family":"Boztug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-2281","authenticated-orcid":false,"given":"Florian","family":"Grebien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"59930_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nm.4439","volume":"24","author":"H Bolouri","year":"2018","unstructured":"Bolouri, H. et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat. Med. 24, 103\u2013112 (2018).","journal-title":"Nat. Med."},{"key":"59930_CR2","doi-asserted-by":"crossref","unstructured":"Michmerhuizen, N. L., Klco, J. M. & Mullighan, C. G. Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies. Blood 136, 2275\u20132289 (2020).","DOI":"10.1182\/blood.2020007093"},{"key":"59930_CR3","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1182\/blood-2011-07-328880","volume":"118","author":"SM Gough","year":"2011","unstructured":"Gough, S. M., Slape, C. I. & Aplan, P. D. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 118, 6247\u20136257 (2011).","journal-title":"Blood"},{"key":"59930_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70013","volume":"8","author":"M Rasouli","year":"2024","unstructured":"Rasouli, M. et al. NUP98 oncofusions in myeloid malignancies: an update on molecular mechanisms and therapeutic opportunities. HemaSphere 8, e70013 (2024).","journal-title":"HemaSphere"},{"key":"59930_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/gcc.20308","volume":"45","author":"LJCM Van Zutven","year":"2006","unstructured":"Van Zutven, L. J. C. M. et al. Identification of NUP98 abnormalities in acute leukemia: JARIDIA (12p13) as a new partner gene. Genes Chromosom. Cancer 45, 437\u2013446 (2006).","journal-title":"Genes Chromosom. Cancer"},{"key":"59930_CR6","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/leu.2013.87","volume":"27","author":"J De Rooij","year":"2013","unstructured":"De Rooij, J. et al. NUP98\/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia 27, 2280\u20132288 (2013).","journal-title":"Leukemia"},{"key":"59930_CR7","doi-asserted-by":"crossref","unstructured":"Bertrums, E. J. M. et al. Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. Haematologica 108, 0390\u20136078 (2023).","DOI":"10.3324\/haematol.2022.281653"},{"key":"59930_CR8","doi-asserted-by":"crossref","unstructured":"Noort, S. et al. The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia. Haematologica 106, 0390\u20136078 (2020).","DOI":"10.3324\/haematol.2019.236745"},{"key":"59930_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nature08036","volume":"459","author":"GG Wang","year":"2009","unstructured":"Wang, G. G. et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 459, 847\u2013851 (2009).","journal-title":"Nature"},{"key":"59930_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1182\/blood.2019003267","volume":"136","author":"J Schmoellerl","year":"2020","unstructured":"Schmoellerl, J. et al. CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia. Blood 136, 387\u2013400 (2020).","journal-title":"Blood"},{"key":"59930_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41594-020-00550-w","volume":"28","author":"S Terlecki-Zaniewicz","year":"2021","unstructured":"Terlecki-Zaniewicz, S. et al. Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression. Nat. Struct. Mol. Biol. 28, 190\u2013201 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"59930_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ccell.2016.10.019","volume":"30","author":"H Xu","year":"2016","unstructured":"Xu, H. et al. NUP98 fusion proteins interact with the NSL and MLL1 complexes to drive leukemogenesis. Cancer Cell 30, 863\u2013878 (2016).","journal-title":"Cancer Cell"},{"key":"59930_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41586-021-03662-5","volume":"595","author":"JH Ahn","year":"2021","unstructured":"Ahn, J. H. et al. Phase separation drives aberrant chromatin looping and cancer development. Nature 595, 591\u2013595 (2021).","journal-title":"Nature"},{"key":"59930_CR14","doi-asserted-by":"crossref","unstructured":"Heikamp, E. B. et al. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. Blood 139, 894\u2013906 (2022).","DOI":"10.1182\/blood.2021012806"},{"key":"59930_CR15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1128\/MCB.19.1.764","volume":"19","author":"LH Kasper","year":"1999","unstructured":"Kasper, L. H. et al. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol. Cell. Biol. 19, 764\u2013776 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"59930_CR16","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1158\/0008-5472.CAN-05-3101","volume":"66","author":"XT Bai","year":"2006","unstructured":"Bai, X. T. et al. Trans-repressive effect of NUP98-PMX1 on PMX1-regulated c-FOS gene through recruitment of histone deacetylase 1 by FG repeats. Cancer Res. 66, 4584\u20134590 (2006).","journal-title":"Cancer Res."},{"key":"59930_CR17","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1158\/2159-8290.CD-21-0674","volume":"12","author":"B Chandra","year":"2022","unstructured":"Chandra, B. et al. Phase separation mediates NUP98 fusion oncoprotein leukemic transformation. Cancer Discov. 12, 1152\u20131169 (2022).","journal-title":"Cancer Discov."},{"key":"59930_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13046-022-02248-x","volume":"41","author":"Z Jevtic","year":"2022","unstructured":"Jevtic, Z. et al. SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation. J. Exp. Clin. Cancer Res. 41, 34 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"59930_CR19","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1182\/bloodadvances.2021005381","volume":"6","author":"G Yamato","year":"2022","unstructured":"Yamato, G. et al. Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia. Blood Adv. 6, 3207\u20133219 (2022).","journal-title":"Blood Adv."},{"key":"59930_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0609.1996.tb00483.x","volume":"57","author":"I Olsson","year":"1996","unstructured":"Olsson, I., Bergh, G., Ehinger, M. & Gullberg, U. Cell differentiation in acute myeloid leukemia. Eur. J. Haematol. 57, 1\u201316 (1996).","journal-title":"Eur. J. Haematol."},{"key":"59930_CR21","doi-asserted-by":"publisher","first-page":"24593","DOI":"10.1073\/pnas.1904091116","volume":"116","author":"A Agarwal","year":"2019","unstructured":"Agarwal, A. et al. Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 116, 24593\u201324599 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59930_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/19491034.2022.2143106","volume":"13","author":"AR Mansisidor","year":"2022","unstructured":"Mansisidor, A. R. & Risca, V. I. Chromatin accessibility: methods, mechanisms, and biological insights. Nucleus 13, 236 (2022).","journal-title":"Nucleus"},{"key":"59930_CR23","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/2159-8290.CD-20-1230","volume":"11","author":"C McLeod","year":"2021","unstructured":"McLeod, C. et al. St. Jude Cloud\u2014a pediatric cancer genomic data sharing ecosystem. Cancer Discov. 11, 1082 (2021).","journal-title":"Cancer Discov."},{"key":"59930_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41589-018-0021-8","volume":"14","author":"B Nabet","year":"2018","unstructured":"Nabet, B. et al. The dTAG system for immediate and target-specific protein degradation. Nat. Chem. Biol. 14, 431\u2013441 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"59930_CR25","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aab1433","volume":"348","author":"GE Winter","year":"2015","unstructured":"Winter, G. E. et al. Selective target protein degradation via phthalimide conjugation. Science 348, 1376 (2015).","journal-title":"Science"},{"key":"59930_CR26","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/leu.2016.19","volume":"30","author":"VP Lavall\u00e9e","year":"2016","unstructured":"Lavall\u00e9e, V. P. et al. Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations. Leukemia 30, 1621\u20131624 (2016).","journal-title":"Leukemia"},{"key":"59930_CR27","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nmeth.4435","volume":"14","author":"VA Herzog","year":"2017","unstructured":"Herzog, V. A. et al. Thiol-linked alkylation of RNA to assess expression dynamics. Nat. Methods 14, 1198\u20131204 (2017).","journal-title":"Nat. Methods"},{"key":"59930_CR28","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1126\/science.aao2793","volume":"360","author":"M Muhar","year":"2018","unstructured":"Muhar, M. et al. SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis. Science 360, 800\u2013805 (2018).","journal-title":"Science"},{"key":"59930_CR29","doi-asserted-by":"crossref","unstructured":"Olsen, S. N. et al. MLL::AF9 degradation induces rapid changes in transcriptional elongation and subsequent loss of an active chromatin landscape. Mol. Cell 82, 1140\u20131155 (2022).","DOI":"10.1016\/j.molcel.2022.02.013"},{"key":"59930_CR30","doi-asserted-by":"publisher","first-page":"14028","DOI":"10.1073\/pnas.0506464102","volume":"102","author":"ZB Xia","year":"2005","unstructured":"Xia, Z. B. et al. The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression. Proc. Natl. Acad. Sci. USA 102, 14028\u201314033 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59930_CR31","doi-asserted-by":"publisher","first-page":"11434","DOI":"10.3390\/ijms222111434","volume":"22","author":"S Nagel","year":"2021","unstructured":"Nagel, S., Pommerenke, C., Meyer, C. & Macleod, R. A. F. Nkl homeobox genes nkx2-3 and nkx2-4 deregulate megakaryocytic-erythroid cell differentiation in aml. Int. J. Mol. Sci. 22, 11434 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"59930_CR32","doi-asserted-by":"crossref","unstructured":"Tran, T. M. et al. The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis. Leukemia 36, 68\u201379 (2021).","DOI":"10.1038\/s41375-021-01346-7"},{"key":"59930_CR33","doi-asserted-by":"publisher","first-page":"e15706","DOI":"10.7717\/peerj.15706","volume":"11","author":"J Fan","year":"2023","unstructured":"Fan, J., Zhuang, M., Fan, W. & Hou, M. RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA. PeerJ 11, e15706 (2023).","journal-title":"PeerJ"},{"key":"59930_CR34","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood-2007-03-080523","volume":"110","author":"M Heuser","year":"2007","unstructured":"Heuser, M. et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood 110, 1639\u20131647 (2007).","journal-title":"Blood"},{"key":"59930_CR35","doi-asserted-by":"crossref","unstructured":"Lei, H. et al. CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer. Cell Death Dis. 12, 740 (2021).","DOI":"10.1038\/s41419-021-04027-6"},{"key":"59930_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-34179-8","volume":"13","author":"T Houles","year":"2022","unstructured":"Houles, T. et al. CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma. Nat. Commun. 13, 1\u201316 (2022).","journal-title":"Nat. Commun."},{"key":"59930_CR37","doi-asserted-by":"crossref","unstructured":"Filippone, M. G. et al. CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer. Nat. Commun. 13, 2642 (2022).","DOI":"10.1038\/s41467-022-30375-8"},{"key":"59930_CR38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ccell.2017.12.009","volume":"33","author":"AB Iniguez","year":"2018","unstructured":"Iniguez, A. B. et al. EWS\/FLI confers tumor cell synthetic lethality to CDK12 inhibition in Ewing sarcoma. Cancer Cell 33, 202\u2013216.e6 (2018).","journal-title":"Cancer Cell"},{"key":"59930_CR39","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1158\/0008-5472.CAN-16-2374","volume":"77","author":"DG Valerio","year":"2017","unstructured":"Valerio, D. G. et al. Histone acetyltransferase activity of MOF is required for MLL-AF9 leukemogenesis. Cancer Res. 77, 1753 (2017).","journal-title":"Cancer Res."},{"key":"59930_CR40","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.cell.2018.01.032","volume":"172","author":"T Hoshii","year":"2018","unstructured":"Hoshii, T. et al. A non-catalytic function of SETD1A regulates cyclin K and the DNA DAMAGE Response. Cell 172, 1007\u20131021.e17 (2018).","journal-title":"Cell"},{"key":"59930_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood.2022016592","volume":"141","author":"J Schmoellerl","year":"2023","unstructured":"Schmoellerl, J. et al. EVI1 drives leukemogenesis through aberrant ERG activation. Blood 141, 453\u2013466 (2023).","journal-title":"Blood"},{"key":"59930_CR42","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/0092-8674(91)90099-K","volume":"65","author":"ML Mucenski","year":"1991","unstructured":"Mucenski, M. L. et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65, 677\u2013689 (1991).","journal-title":"Cell"},{"key":"59930_CR43","doi-asserted-by":"publisher","first-page":"21689","DOI":"10.1073\/pnas.0907623106","volume":"106","author":"YK Lieu","year":"2009","unstructured":"Lieu, Y. K. & Reddy, E. P. Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc. Natl. Acad. Sci. USA 106, 21689\u201321694 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59930_CR44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41375-023-01810-6","volume":"37","author":"ML Trempenau","year":"2023","unstructured":"Trempenau, M. L. et al. The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes. Leukemia 37, 593 (2023).","journal-title":"Leukemia"},{"key":"59930_CR45","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1172\/JCI80046","volume":"126","author":"JK Palanichamy","year":"2016","unstructured":"Palanichamy, J. K. et al. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. J. Clin. Invest. 126, 1495\u20131511 (2016).","journal-title":"J. Clin. Invest."},{"key":"59930_CR46","doi-asserted-by":"crossref","unstructured":"Fan, Z. et al. CDK13 cooperates with CDK12 to control global RNA polymerase II processivity. Sci. Adv. 6, eaaz5041 (2020).","DOI":"10.1126\/sciadv.aaz5041"},{"key":"59930_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-018-0758-y","volume":"564","author":"SJ Dubbury","year":"2018","unstructured":"Dubbury, S. J., Boutz, P. L. & Sharp, P. A. CDK12 regulates DNA repair genes by suppressing intronic polyadenylation. Nat 564, 141\u2013145 (2018).","journal-title":"Nat"},{"key":"59930_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105030","volume":"25","author":"B Magnuson","year":"2022","unstructured":"Magnuson, B. et al. CDK12 regulates co-transcriptional splicing and RNA turnover in human cells. iScience 25, 105030 (2022).","journal-title":"iScience"},{"key":"59930_CR49","doi-asserted-by":"publisher","first-page":"113481","DOI":"10.1016\/j.ejmech.2021.113481","volume":"221","author":"B Jiang","year":"2021","unstructured":"Jiang, B. et al. Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12\/13 covalent inhibitor with efficacy in Ewing sarcoma. Eur. J. Med. Chem. 221, 113481 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"59930_CR50","doi-asserted-by":"publisher","first-page":"101752","DOI":"10.1016\/j.xcrm.2024.101752","volume":"5","author":"Y Chang","year":"2024","unstructured":"Chang, Y. et al. Development of an orally bioavailable CDK12\/13 degrader and induction of synthetic lethality with AKT pathway inhibition. Cell Rep. Med. 5, 101752 (2024).","journal-title":"Cell Rep. Med."},{"key":"59930_CR51","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41589-021-00765-y","volume":"17","author":"B Jiang","year":"2021","unstructured":"Jiang, B. et al. Discovery and resistance mechanism of a selective CDK12 degrader. Nat. Chem. Biol. 17, 675\u2013683 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"59930_CR52","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccell.2019.09.004","volume":"36","author":"V Quereda","year":"2019","unstructured":"Quereda, V. et al. Therapeutic targeting of CDK12\/CDK13 in triple-negative breast cancer. Cancer Cell 36, 545\u2013558.e7 (2019).","journal-title":"Cancer Cell"},{"key":"59930_CR53","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1074\/jbc.M114.551143","volume":"289","author":"PM Joshi","year":"2014","unstructured":"Joshi, P. M., Sutor, S. L., Huntoon, C. J. & Karnitz, L. M. Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors. J. Biol. Chem. 289, 9247\u20139253 (2014).","journal-title":"J. Biol. Chem."},{"key":"59930_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nbt.1720","volume":"29","author":"J Zuber","year":"2011","unstructured":"Zuber, J. et al. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat. Biotechnol. 29, 79 (2011).","journal-title":"Nat. Biotechnol."},{"key":"59930_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ccr.2008.02.008","volume":"13","author":"P Kirstetter","year":"2008","unstructured":"Kirstetter, P. et al. Modeling of C\/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell 13, 299\u2013310 (2008).","journal-title":"Cancer Cell"},{"key":"59930_CR56","doi-asserted-by":"crossref","unstructured":"Savoy, L. et al. CDK12\/13 dual inhibitors are potential therapeutics for acute myeloid leukemia. Br. J. Haematol. 202, 195\u2013198 (2023).","DOI":"10.1111\/bjh.18843"},{"key":"59930_CR57","doi-asserted-by":"crossref","unstructured":"B\u00f6sken, C. A. et al. The structure and substrate specificity of human Cdk12\/Cyclin K. Nat. Commun. 5, 3505 (2014).","DOI":"10.1038\/ncomms4505"},{"key":"59930_CR58","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nchembio.2166","volume":"12","author":"T Zhang","year":"2016","unstructured":"Zhang, T. et al. Covalent targeting of remote cysteine residues to develop CDK12 and 13 inhibitors. Nat. Chem. Biol. 12, 876 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"59930_CR59","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0960-9822(00)00610-2","volume":"10","author":"TT Paull","year":"2000","unstructured":"Paull, T. T. et al. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10, 886\u2013895 (2000).","journal-title":"Curr. Biol."},{"key":"59930_CR60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/17474086.2021.1875814","volume":"14","author":"A Bazinet","year":"2021","unstructured":"Bazinet, A. & Assouline, S. A review of FDA-approved acute myeloid leukemia therapies beyond \u20187 + 3\u2019. Expert Rev. Hematol. 14, 185\u2013197 (2021).","journal-title":"Expert Rev. Hematol."},{"key":"59930_CR61","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/s41375-019-0402-3","volume":"33","author":"NA McNeer","year":"2019","unstructured":"McNeer, N. A. et al. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia. Leukemia 33, 1934\u20131943 (2019).","journal-title":"Leukemia"},{"key":"59930_CR62","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/ncb1608","volume":"9","author":"GG Wang","year":"2007","unstructured":"Wang, G. G., Cai, L., Pasillas, M. P. & Kamps, M. P. NUP98\u2013NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat. Cell Biol. 9, 804\u2013812 (2007).","journal-title":"Nat. Cell Biol."},{"key":"59930_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers11121874","volume":"11","author":"S Nagel","year":"2019","unstructured":"Nagel, S. & Drexler, H. G. Deregulated NKL homeobox genes in B-cell lymphoma. Cancers (Basel) 11, 1\u201315 (2019).","journal-title":"Cancers (Basel)"},{"key":"59930_CR64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/leu.2017.176","volume":"32","author":"P Villarese","year":"2017","unstructured":"Villarese, P. et al. TCR\u03b1 rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome. Leukemia 32, 61\u201371 (2017).","journal-title":"Leukemia"},{"key":"59930_CR65","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1182\/blood-2010-12-324699","volume":"117","author":"QF Wang","year":"2011","unstructured":"Wang, Q. F. et al. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood 117, 6895\u20136905 (2011).","journal-title":"Blood"},{"key":"59930_CR66","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/cas.14033","volume":"110","author":"Y Chu","year":"2019","unstructured":"Chu, Y. et al. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia. Cancer Sci. 110, 2200 (2019).","journal-title":"Cancer Sci."},{"key":"59930_CR67","doi-asserted-by":"crossref","unstructured":"Zhang, L. S. et al. Installation of a cancer promoting WNT\/SIX1 signaling axis by the oncofusion protein MLL-AF9. EBioMedicine 39, 145 (2019).","DOI":"10.1016\/j.ebiom.2018.11.039"},{"key":"59930_CR68","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2018.03.016","volume":"173","author":"N Liu","year":"2018","unstructured":"Liu, N. et al. Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch. Cell 173, 430 (2018).","journal-title":"Cell"},{"key":"59930_CR69","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/bloodadvances.2021004558","volume":"6","author":"Y Sunami","year":"2022","unstructured":"Sunami, Y. et al. BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes. Blood Adv. 6, 1827\u20131843 (2022).","journal-title":"Blood Adv."},{"key":"59930_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2217\/pgs-2017-0157","volume":"19","author":"G Xutao","year":"2018","unstructured":"Xutao, G. et al. BCL11A and MDR1 expressions have prognostic impact in patients with acute myeloid leukemia treated with chemotherapy. Pharmacogenomics 19, 343\u2013348 (2018).","journal-title":"Pharmacogenomics"},{"key":"59930_CR71","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fcell.2019.00363","volume":"7","author":"C Mancarella","year":"2020","unstructured":"Mancarella, C. & Scotlandi, K. IGF2BP3 from physiology to cancer: novel discoveries, unsolved issues, and future perspectives. Front. Cell Dev. Biol. 7, 363 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"59930_CR72","doi-asserted-by":"crossref","unstructured":"Liu, X. et al. Targeting IGF2BP3 in Cancer. Int. J. Mol. Sci. 24, 9423 (2023).","DOI":"10.3390\/ijms24119423"},{"key":"59930_CR73","doi-asserted-by":"publisher","first-page":"188842","DOI":"10.1016\/j.bbcan.2022.188842","volume":"1878","author":"W Wu","year":"2023","unstructured":"Wu, W., Yu, S. & Yu, X. Transcription-associated cyclin-dependent kinase 12 (CDK12) as a potential target for cancer therapy. Biochim. Biophys. Acta - Rev. Cancer 1878, 188842 (2023).","journal-title":"Biochim. Biophys. Acta - Rev. Cancer"},{"key":"59930_CR74","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1101\/gad.16962311","volume":"25","author":"D Blazek","year":"2011","unstructured":"Blazek, D. et al. The Cyclin K\/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev. 25, 2158 (2011).","journal-title":"Genes Dev."},{"key":"59930_CR75","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/2159-8290.CD-17-1461","volume":"8","author":"P Kotsantis","year":"2018","unstructured":"Kotsantis, P., Petermann, E. & Boulton, S. J. Mechanisms of oncogene-induced replication stress: jigsaw falling into place. Cancer Discov. 8, 537 (2018).","journal-title":"Cancer Discov."},{"key":"59930_CR76","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.trecan.2021.04.006","volume":"7","author":"A Bowry","year":"2021","unstructured":"Bowry, A., Kelly, R. D. W. & Petermann, E. Hypertranscription and replication stress in cancer. Trends Cancer 7, 863\u2013877 (2021).","journal-title":"Trends Cancer"},{"key":"59930_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-51229-5","volume":"15","author":"L Curti","year":"2024","unstructured":"Curti, L. et al. CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflicts. Nat. Commun. 15, 1\u201318 (2024).","journal-title":"Nat. Commun."},{"key":"59930_CR78","doi-asserted-by":"crossref","unstructured":"Yang, Y. et al. Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer. Nat. Cancer 5, 1885\u20131901 (2024).","DOI":"10.1038\/s43018-024-00848-4"},{"key":"59930_CR79","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783 (2014).","journal-title":"Nat. Methods"},{"key":"59930_CR80","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41592-020-0850-8","volume":"17","author":"G Michlits","year":"2020","unstructured":"Michlits, G. et al. Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles. Nat. Methods 17, 708\u2013716 (2020).","journal-title":"Nat. Methods"},{"key":"59930_CR81","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","volume":"5","author":"C Fellmann","year":"2013","unstructured":"Fellmann, C. et al. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep. 5, 1704\u20131713 (2013).","journal-title":"Cell Rep."},{"key":"59930_CR82","doi-asserted-by":"crossref","unstructured":"Kodali, S. et al. RNA sequestration in P-bodies sustains myeloid leukaemia. Nat. Cell Biol. 26, 1745\u20131758 (2024).","DOI":"10.1038\/s41556-024-01489-6"},{"key":"59930_CR83","doi-asserted-by":"crossref","unstructured":"Skucha, A. et al. MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. Nat. Commun. 9, 1983 (2018).","DOI":"10.1038\/s41467-018-04329-y"},{"key":"59930_CR84","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10334","volume":"478","author":"J Zuber","year":"2011","unstructured":"Zuber, J. et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nat 478, 524\u2013528 (2011).","journal-title":"Nat"},{"key":"59930_CR85","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1182\/blood-2010-11-320309","volume":"118","author":"M Schmitz","year":"2011","unstructured":"Schmitz, M. et al. Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood 118, 1854\u20131864 (2011).","journal-title":"Blood"},{"key":"59930_CR86","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/s41375-019-0382-3","volume":"33","author":"L Schmidt","year":"2019","unstructured":"Schmidt, L. et al. CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex. Leukemia 33, 1608\u20131619 (2019).","journal-title":"Leukemia"},{"key":"59930_CR87","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/bs.mcb.2018.11.002","volume":"151","author":"T Shashikant","year":"2019","unstructured":"Shashikant, T. & Ettensohn, C. A. Genome-wide analysis of chromatin accessibility using ATAC-seq. Methods Cell Biol. 151, 219\u2013235 (2019).","journal-title":"Methods Cell Biol."},{"key":"59930_CR88","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41586-021-04035-8","volume":"599","author":"M de Almeida","year":"2021","unstructured":"de Almeida, M. et al. AKIRIN2 controls the nuclear import of proteasomes in vertebrates. Nature 599, 491\u2013496 (2021).","journal-title":"Nature"},{"key":"59930_CR89","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nbt.3820","volume":"35","author":"P Di Tommaso","year":"2017","unstructured":"Di Tommaso, P. et al. Nextflow enables reproducible computational workflows. Nat. Biotechnol. 35, 316\u2013319 (2017).","journal-title":"Nat. Biotechnol."},{"key":"59930_CR90","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"59930_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"59930_CR92","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/bioinformatics\/btr026","volume":"27","author":"R Schmieder","year":"2011","unstructured":"Schmieder, R. & Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 27, 863\u2013864 (2011).","journal-title":"Bioinformatics"},{"key":"59930_CR93","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"59930_CR94","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"59930_CR95","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"59930_CR96","doi-asserted-by":"crossref","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"59930_CR97","unstructured":"Warnes, G. et al. gplots: Various R Programming Tools for Plotting Data. CRAN. R package version 3.2.0, https:\/\/CRAN.R-project.org\/package=gplots (2024)."},{"key":"59930_CR98","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/bioinformatics\/btl056","volume":"22","author":"A Conesa","year":"2006","unstructured":"Conesa, A., Nueda, M. J., Ferrer, A. & Tal\u00f3n, M. maSigPro: a method to identify significantly differential expression profiles in time-course microarray experiments. Bioinformatics 22, 1096\u20131102 (2006).","journal-title":"Bioinformatics"},{"key":"59930_CR99","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59930_CR100","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"59930_CR101","doi-asserted-by":"publisher","first-page":"W207","DOI":"10.1093\/nar\/gkad347","volume":"51","author":"L Kolberg","year":"2023","unstructured":"Kolberg, L. et al. g:Profiler\u2014interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res. 51, W207\u2013W212 (2023).","journal-title":"Nucleic Acids Res."},{"key":"59930_CR102","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: A free online platform for data visualization and graphing. PLoS ONE 18, e0294236 (2023).","journal-title":"PLoS ONE"},{"key":"59930_CR103","doi-asserted-by":"publisher","unstructured":"Krueger, F. et al. FelixKrueger\/TrimGalore: v0.6.10, Zenodo. https:\/\/doi.org\/10.5281\/zenodo.7598955 (2023).","DOI":"10.5281\/zenodo.7598955"},{"key":"59930_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-2849-7","volume":"20","author":"T Neumann","year":"2019","unstructured":"Neumann, T. et al. Quantification of experimentally induced nucleotide conversions in high-throughput sequencing datasets. BMC Bioinformatics. 20, 258 (2019).","journal-title":"BMC Bioinformatics"},{"key":"59930_CR105","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"59930_CR106","doi-asserted-by":"publisher","first-page":"W187","DOI":"10.1093\/nar\/gku365","volume":"42","author":"F Ramirez","year":"2014","unstructured":"Ramirez, F., Dundar, F., Diehl, S., Gruning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187\u2013W191 (2014).","journal-title":"Nucleic Acids Res."},{"key":"59930_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"59930_CR108","doi-asserted-by":"crossref","unstructured":"Ross-Innes, C. et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389\u2013393 (2012).","DOI":"10.1038\/nature10730"},{"key":"59930_CR109","doi-asserted-by":"publisher","unstructured":"Carroll, T. & Barrows, D. profileplyr https:\/\/doi.org\/10.18129\/B9.BIOC.PROFILEPLYR.","DOI":"10.18129\/B9.BIOC.PROFILEPLYR"},{"key":"59930_CR110","doi-asserted-by":"crossref","unstructured":"Wickham, H. Ggplot2: Elegant Graphics for Data Analysis. Use R! CN - QA90.W53 2009 (Springer, 2009).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"59930_CR111","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"59930_CR112","doi-asserted-by":"publisher","unstructured":"Reichl, S. et al. Ultimate ATAC-seq Data Processing & Analysis Pipeline: v0.1.1, Zenodo. https:\/\/doi.org\/10.5281\/ZENODO.6346319 (2022).","DOI":"10.5281\/ZENODO.6346319"},{"key":"59930_CR113","doi-asserted-by":"publisher","first-page":"111288","DOI":"10.1016\/j.celrep.2022.111288","volume":"40","author":"T Casteels","year":"2022","unstructured":"Casteels, T. et al. SMNDC1 links chromatin remodeling and splicing to regulate pancreatic hormone expression. Cell Rep. 40, 111288 (2022).","journal-title":"Cell Rep."},{"key":"59930_CR114","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"59930_CR115","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/bioinformatics\/btu314","volume":"30","author":"GG Faust","year":"2014","unstructured":"Faust, G. G. & Hall, I. M. SAMBLASTER: fast duplicate marking and structural variant read extraction. Bioinformatics 30, 2503\u20132505 (2014).","journal-title":"Bioinformatics"},{"key":"59930_CR116","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L.-G. & He, Q.-Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383 (2015).","journal-title":"Bioinformatics"},{"key":"59930_CR117","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"59930_CR118","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1654-1103.2003.tb02228.x","volume":"14","author":"P Dixon","year":"2003","unstructured":"Dixon, P. VEGAN, a package of R functions for community ecology. J. Veg. Sci. 14, 927\u2013930 (2003).","journal-title":"J. Veg. Sci."},{"key":"59930_CR119","unstructured":"Oksanen, J. et al. vegan: Community Ecology Package. CRAN. R package version 2.6-8, https:\/\/CRAN.R-project.org\/package=vegan (2024)."},{"key":"59930_CR120","unstructured":"Pedersen, T. ggraph: An Implementation of Grammar of Graphics for Graphs and Networks. CRAN. R package version 2.2.1, https:\/\/CRAN.R-project.org\/package=ggraph (2024)."},{"key":"59930_CR121","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576 (2010).","journal-title":"Mol. Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59930-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59930-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59930-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T14:03:50Z","timestamp":1747663430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59930-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59930"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59930-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"6 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.Z. is a founder, shareholder, and scientific advisor of Quantro Therapeutics GmbH. J.Z. and the Zuber laboratory receive research support and funding from Boehringer Ingelheim. P.V. received consultancy honoraria from Pfizer, AOP Orphan, Delbert, Novartis, and Blueprint. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4656"}}